|
 |
|
|||||||
|
|||||||||
Copyright ©ERS Journals Ltd 2008
Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction
Section of Airways Disease, National Heart and Lung Institute, Imperial College London, London, UK.
CORRESPONDENCE: K. F. Chung, National Heart and Lung Institute, Imperial College London, Dovehouse Street, London, SW3 6LY, UK. Fax: 44 2073518126. E-mail: f.chung{at}imperial.ac.uk
Keywords: Autoimmunity, chronic obstructive pulmonary disease, macrophages, neutrophil, oxidative stress, senescence
Received: February 7, 2008
Accepted February 15, 2008
Chronic obstructive pulmonary disease is a leading global cause of morbidity and mortality that is characterised by inexorable deterioration of small airways obstruction with emphysema associated with cellular inflammation and structural remodelling. Other features include apoptosis as well as proliferation of cells, and both tissue repair and lack of tissue repair.
Metalloprotease release, together with that of apoptotic factors, may underlie the emphysema, and, conversely, fibrosis of the small airways may be accounted for by the effects of growth factor activation. In advanced disease, influential factors include the development of autoimmunity, with activation of dendritic cells and T-helper cells of both type 1 and 2, and the senescence response.
An inability of macrophages to ingest apoptosed cells and bacteria may exacerbate inflammatory responses. Systemic inflammation with concomitant cardiovascular disease and metabolic syndrome may reflect the effect of cigarette smoke on nonpulmonary cells. Corticosteroid resistance may be secondary to oxidative stress mechanisms, such as inactivation of histone deacetylases.
The mechanisms of chronic obstructive pulmonary disease may be heterogeneous, according to severity, and clinical phenotypes need to be correlated with cellular and pathological processes. Treatments may be targeted to patients with specific mechanisms.
This article has been cited by other articles:
|
|
 |
|
  J. A. Marwick, Kian Fan Chung, and I. M. Adcock Phosphatidylinositol 3-kinase isoforms as targets in respiratory disease Therapeutic Advances in Respiratory Disease, February 1, 2010; 4(1): 19 - 34. [Abstract] [PDF]
|
|
|
|
 |
|
 D. Malhotra, R. Thimmulappa, N. Vij, A. Navas-Acien, T. Sussan, S. Merali, L. Zhang, S. G. Kelsen, A. Myers, R. Wise, et al. Heightened Endoplasmic Reticulum Stress in the Lungs of Patients with Chronic Obstructive Pulmonary Disease: The Role of Nrf2-Regulated Proteasomal Activity Am. J. Respir. Crit. Care Med., December 15, 2009; 180(12): 1196 - 1207. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Sharma, N. A. Hanania, and Y. M. Shim The Aging Immune System and Its Relationship to the Development of Chronic Obstructive Pulmonary Disease Proceedings of the ATS, December 1, 2009; 6(7): 573 - 580. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Fens, A. H. Zwinderman, M. P. van der Schee, S. B. de Nijs, E. Dijkers, A. C. Roldaan, D. Cheung, E. H. Bel, and P. J. Sterk Exhaled Breath Profiling Enables Discrimination of Chronic Obstructive Pulmonary Disease and Asthma Am. J. Respir. Crit. Care Med., December 1, 2009; 180(11): 1076 - 1082. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. L. Clanton and S. Levine Respiratory muscle fiber remodeling in chronic hyperinflation: dysfunction or adaptation? J Appl Physiol, July 1, 2009; 107(1): 324 - 335. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Mejia, G. Carrillo, J. Rojas-Serrano, A. Estrada, T. Suarez, D. Alonso, E. Barrientos, M. Gaxiola, C. Navarro, and M. Selman Idiopathic Pulmonary Fibrosis and Emphysema: Decreased Survival Associated With Severe Pulmonary Arterial Hypertension Chest, July 1, 2009; 136(1): 10 - 15. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Braman Chronic Obstructive Pulmonary Disease ACCP Pulmonary Med Brd Rev, January 1, 2009; 25(0): 153 - 186. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |